ITMI20031313A0 - Associazione di agenti vasoprotettori e formazioni che li contengono - Google Patents

Associazione di agenti vasoprotettori e formazioni che li contengono

Info

Publication number
ITMI20031313A0
ITMI20031313A0 IT2003MI001313A ITMI20031313A ITMI20031313A0 IT MI20031313 A0 ITMI20031313 A0 IT MI20031313A0 IT 2003MI001313 A IT2003MI001313 A IT 2003MI001313A IT MI20031313 A ITMI20031313 A IT MI20031313A IT MI20031313 A0 ITMI20031313 A0 IT MI20031313A0
Authority
IT
Italy
Prior art keywords
trainings
association
contain
vasoprotective agents
vasoprotective
Prior art date
Application number
IT2003MI001313A
Other languages
English (en)
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT001313A priority Critical patent/ITMI20031313A1/it
Publication of ITMI20031313A0 publication Critical patent/ITMI20031313A0/it
Priority to TR2019/00241T priority patent/TR201900241T4/tr
Priority to RU2005140574/13A priority patent/RU2361430C2/ru
Priority to CA2530660A priority patent/CA2530660C/en
Priority to JP2006515963A priority patent/JP4960087B2/ja
Priority to HUE04739969A priority patent/HUE042048T2/hu
Priority to PL04739969T priority patent/PL1638417T3/pl
Priority to DK04739969.6T priority patent/DK1638417T3/en
Priority to BRPI0411811-1A priority patent/BRPI0411811B1/pt
Priority to CNB2004800177716A priority patent/CN100475061C/zh
Priority to EP04739969.6A priority patent/EP1638417B1/en
Priority to PCT/EP2004/006507 priority patent/WO2005000041A1/en
Priority to US10/562,214 priority patent/US20090036520A1/en
Priority to KR1020057024537A priority patent/KR101165934B1/ko
Priority to ES04739969T priority patent/ES2704633T3/es
Priority to NZ544399A priority patent/NZ544399A/en
Priority to MXPA05013625A priority patent/MXPA05013625A/es
Priority to PT04739969T priority patent/PT1638417T/pt
Priority to AU2004251009A priority patent/AU2004251009B2/en
Priority to SI200432457T priority patent/SI1638417T1/sl
Publication of ITMI20031313A1 publication Critical patent/ITMI20031313A1/it
Priority to NO20056162A priority patent/NO330523B1/no
Priority to HK06111347.1A priority patent/HK1090519A1/xx
Priority to RU2009109089/13A priority patent/RU2489907C2/ru
Priority to US12/721,015 priority patent/US20100160427A1/en
Priority to US13/033,826 priority patent/US8206759B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IT001313A 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono. ITMI20031313A1 (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.
SI200432457T SI1638417T1 (sl) 2003-06-27 2004-06-17 Kombinacije vazoprotektivnih sredstev in formulacije, ki jih vsebujejo
US10/562,214 US20090036520A1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
ES04739969T ES2704633T3 (es) 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que los contienen
CA2530660A CA2530660C (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
JP2006515963A JP4960087B2 (ja) 2003-06-27 2004-06-17 血管保護物質の組合せおよびそれらを含む製剤
HUE04739969A HUE042048T2 (hu) 2003-06-27 2004-06-17 Vazoprotektív szerek kombinációi és ezeket tartalmazó készítmények
PL04739969T PL1638417T3 (pl) 2003-06-27 2004-06-17 Kombinacje środków chroniących naczynia i kompozycje zawierające te kombinacje
DK04739969.6T DK1638417T3 (en) 2003-06-27 2004-06-17 COMBINATIONS OF VASO PROTECTIVE AGENTS AND FORMS CONTAINING THESE
BRPI0411811-1A BRPI0411811B1 (pt) 2003-06-27 2004-06-17 Composições farmacêuticas, dietéticas ou nutricionais e emprego de uma combinação de agentes vasoprotetores na preparação de composições hipocolesterolemizantes
CNB2004800177716A CN100475061C (zh) 2003-06-27 2004-06-17 血管保护剂的组合以及含有它们的制剂
EP04739969.6A EP1638417B1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
PCT/EP2004/006507 WO2005000041A1 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
TR2019/00241T TR201900241T4 (tr) 2003-06-27 2004-06-17 Vasoprotektif maddelerin kombinasyonları ve bunları içeren formülasyonlar.
KR1020057024537A KR101165934B1 (ko) 2003-06-27 2004-06-17 혈관보호제들의 합제와 그들을 함유한 제제
RU2005140574/13A RU2361430C2 (ru) 2003-06-27 2004-06-17 Диетическая композиция, содержащая вазопротекторные агенты
NZ544399A NZ544399A (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
MXPA05013625A MXPA05013625A (es) 2003-06-27 2004-06-17 Combinaciones de agentes vasoprotectores y formulaciones que contienen los mismos.
PT04739969T PT1638417T (pt) 2003-06-27 2004-06-17 Combinações de agentes vasoprotetores e formulações que os contêm
AU2004251009A AU2004251009B2 (en) 2003-06-27 2004-06-17 Combinations of vasoprotective agents and formulations containing them
NO20056162A NO330523B1 (no) 2003-06-27 2005-12-23 Kombinasjoner av vasobeskyttende agenser og formuleringer inneholdende dem og anvendelse derav
HK06111347.1A HK1090519A1 (en) 2003-06-27 2006-10-17 Combinations of vasoprotective agents and formulations containing them
RU2009109089/13A RU2489907C2 (ru) 2003-06-27 2009-03-12 Комбинации вазопротекторных агентов и препаративные формы, содержащие такие комбинации
US12/721,015 US20100160427A1 (en) 2003-06-27 2010-03-10 Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents
US13/033,826 US8206759B2 (en) 2003-06-27 2011-02-24 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.

Publications (2)

Publication Number Publication Date
ITMI20031313A0 true ITMI20031313A0 (it) 2003-06-27
ITMI20031313A1 ITMI20031313A1 (it) 2004-12-28

Family

ID=30131309

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001313A ITMI20031313A1 (it) 2003-06-27 2003-06-27 Associazioni di agenti vasoprotettori e formulazioni che li contengono.

Country Status (22)

Country Link
US (3) US20090036520A1 (it)
EP (1) EP1638417B1 (it)
JP (1) JP4960087B2 (it)
KR (1) KR101165934B1 (it)
CN (1) CN100475061C (it)
AU (1) AU2004251009B2 (it)
BR (1) BRPI0411811B1 (it)
CA (1) CA2530660C (it)
DK (1) DK1638417T3 (it)
ES (1) ES2704633T3 (it)
HK (1) HK1090519A1 (it)
HU (1) HUE042048T2 (it)
IT (1) ITMI20031313A1 (it)
MX (1) MXPA05013625A (it)
NO (1) NO330523B1 (it)
NZ (1) NZ544399A (it)
PL (1) PL1638417T3 (it)
PT (1) PT1638417T (it)
RU (2) RU2361430C2 (it)
SI (1) SI1638417T1 (it)
TR (1) TR201900241T4 (it)
WO (1) WO2005000041A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8202541B2 (en) 2006-02-07 2012-06-19 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
US8017153B2 (en) 2006-02-07 2011-09-13 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
JP4469407B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中中性脂肪低下剤
JP4469406B1 (ja) * 2009-06-30 2010-05-26 株式会社ファンケル 血中コレステロール低下剤
KR101294970B1 (ko) * 2011-06-30 2013-08-09 고려대학교 산학협력단 폴리코사놀 에스터, 이의 제조 방법 및 이를 포함하는 첨가제
DK2968209T3 (da) * 2013-03-15 2021-01-04 Nanorx Inc Nanopartikelformuleringer af metadichol®-væske og -gel
IT201900020808A1 (it) * 2019-11-11 2021-05-11 Neilos S R L Composizione per la riduzione del rischio cardiovascolare

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
JP3142245B2 (ja) * 1996-06-28 2001-03-07 株式会社資生堂 皮膚外用剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
JP2001511153A (ja) * 1997-02-04 2001-08-07 ブイ． コスバブ，ジョン 血管変性性疾患の予防および処置のための組成物および方法
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
AU9209898A (en) * 1997-09-02 1999-03-22 Ricex Company, Inc., The A method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis
IT1296920B1 (it) * 1997-12-04 1999-08-03 Indena Spa Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-aterosclerotici
AT407821B (de) * 1998-03-24 2001-06-25 Franz Dr Stueckler Mittel auf der basis von naturstoffen
KR20000019717A (ko) * 1998-09-15 2000-04-15 박호군 루틴 및 쿼세틴을 포함하는 고지혈증, 동맥경화증 및 간 질환의예방 및 치료용 조성물
FR2792831B1 (fr) * 1999-04-28 2001-08-03 Bionatec Sarl Composition a destination cosmetique et/ou dietetique comprenant un melange de lycopene et d'extrait de feuille d'olivier
KR100319397B1 (ko) 1999-07-12 2002-01-05 남 승 우 천연식물소재 추출물을 이용한 항혈전 및 고지혈증 억제 조성물
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US20020120001A1 (en) * 2000-10-13 2002-08-29 Ashni Naturaceuticals, Inc. Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e

Also Published As

Publication number Publication date
DK1638417T3 (en) 2019-01-28
ES2704633T3 (es) 2019-03-19
JP2007519603A (ja) 2007-07-19
AU2004251009B2 (en) 2010-06-17
SI1638417T1 (sl) 2019-02-28
BRPI0411811B1 (pt) 2018-05-29
US20110142967A1 (en) 2011-06-16
RU2005140574A (ru) 2006-05-10
KR101165934B1 (ko) 2012-07-19
KR20060072098A (ko) 2006-06-27
NZ544399A (en) 2009-04-30
MXPA05013625A (es) 2006-02-24
RU2009109089A (ru) 2010-09-20
EP1638417A1 (en) 2006-03-29
PL1638417T3 (pl) 2019-03-29
US20090036520A1 (en) 2009-02-05
CA2530660A1 (en) 2005-01-06
NO330523B1 (no) 2011-05-09
ITMI20031313A1 (it) 2004-12-28
RU2361430C2 (ru) 2009-07-20
CN100475061C (zh) 2009-04-08
US20100160427A1 (en) 2010-06-24
PT1638417T (pt) 2019-01-17
US8206759B2 (en) 2012-06-26
BRPI0411811A (pt) 2006-08-08
AU2004251009A1 (en) 2005-01-06
TR201900241T4 (tr) 2019-02-21
EP1638417B1 (en) 2018-10-10
CA2530660C (en) 2013-08-20
NO20056162L (no) 2005-12-23
RU2489907C2 (ru) 2013-08-20
WO2005000041A1 (en) 2005-01-06
JP4960087B2 (ja) 2012-06-27
HUE042048T2 (hu) 2019-06-28
HK1090519A1 (en) 2006-12-29
CN1812729A (zh) 2006-08-02

Similar Documents

Publication Publication Date Title
NO2017017I1 (no) umeklinidium og vilanterol
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DE602004031564D1 (de) Personenbezogene identifikationseinrichtung
CY2014001I1 (el) Συνδυασμος αζελαστινης και φλουτικαζονης
DK1809622T3 (da) Inhibitorer af interaktionen mellem MDM2 og P53
DE60319430D1 (de) R- und fgfr-inhibitoren
ATE413395T1 (de) N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitor n
NO20054453L (no) P38 inhibitorer og fremgangsmater for anvendelse derav
DK2277976T3 (da) Sammensætninger omfattende hfc-1234ze og smøremiddel
IS8305A (is) Bindandi smíðar og aðferðir við notkun þeirra
ATE354631T1 (de) Nuancierungsmittel
FI20045376A0 (fi) Kanta-asiakaskortti ja siihen liittyviä laitteita
DE602004018837D1 (de) Ptidase-iv-inhibitoren
IS8597A (is) Samsetningar rísedrónats og aðferðir við notkun þess
DE602004021944D1 (de) Spielfigur
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
DK1675852T3 (da) Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
IS8399A (is) Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns
DE602004013477D1 (de) Metallische Keilriemen
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
IS8489A (is) Umritunarstillar og aðferðir þeirra
DE502004006055D1 (de) 6-arylamino-5-cyano-4-pyrimidinone als pde9a-inhibitoren
ITMI20031313A0 (it) Associazione di agenti vasoprotettori e formazioni che li contengono
NO20055668D0 (no) Beta-amyloidinhibitorer og anvendelse derav